02
BEFORE / AFTER

What changed from existing technology?

Previous limitation

This study found that a nutritional score called the Prognostic Nutritional Index (PNI) might help predict if patients with severe liver damage from sepsis will die within 28 days.

→
This research

This is the first study to specifically examine the relationship between the Prognostic Nutritional Index (PNI) and mortality in patients with sepsis-associated liver injury (SALI).

03
COMMERCIALIZATION WATCH

Commercialization signals visible at publication

Publication-time signal score46/100

This is not a success probability or investment opinion. It prioritizes follow-up using evidence available when the paper was published.

Verified evidence · 2
사람 대상·임상 근거

e prognostic nutritional index and 28-day mortality in patients with sepsis-associated liver injury: a retrospective cohort study. The mortality rates of pati

Title ↗
인허가 근거

ween the PNI and mortality rate of patients with SALI remains unclear. Therefore, this study aimed to elucidate the association between the PNI and 28-da

Abstract ↗
Evidence not yet confirmed
  • 시제품·장치 구현 근거 미확인
  • 제조·규모 확장 근거 미확인
Current tracking point2026-09-07 · Paper published

Later patent, company, clinical, and production events are added separately only after verification.

Patent check: Not checked yet
04 · REALITY CHECK

Current technology stage: Near commercialization

See what changed before reading the full paper.

Current stageNear commercialization
Basic researchExperimental validationPrototypeField validationNear commercialization
05
REMAINING CHALLENGES

What still needs to be solved?

Repeated real-world validation, manufacturability, cost, and long-term stability still require follow-up evidence.

06
INDUSTRY OPPORTUNITY

What could change if this succeeds?

07 · ONE MORE POSSIBILITYOne possibility beyond the paper

The Prognostic Nutritional Index (PNI) could potentially be used as a tool to identify sepsis patients with poor prognosis who may need closer monitoring or more aggressive treatment.

09 · EVIDENCE & SOURCES

Evidence and sources